Renowned Peruvian investigative reporter battles criminalized smear campaign — and cancer
LIMA, Peru (AP) — At age 75, one of Latin America’s most storied journalists had been looking forward to weaving into books the fragmented threads of more than four decades of investigative reporting that exposed high-level abuse of power in Peru and abroad.
In an illustrious career, Gustavo Gorriti has endured death threats from drug traffickers, survived Peru’s harrowing Shining Path insurgency and a kidnapping by silencer-toting military intelligence agents during a 1992 presidential power grab.
Then an aggressive lymphatic cancer struck, wasting the former five-time national judo champion’s robust physique. Diagnosed in August, Gorriti was in the final drips of two months of chemotherapy in December when a different kind of body blow landed.
A smear campaign — amplified by complicit, cowed or indifferent broadcast and print media — portrayed the self-styled “intelligence agent for the people” as Public Enemy No. 1, a ruthless, egotistical victimizer of innocents.
Related articles
Why US Catholics are planning pilgrimages in communities across the nation
A long-planned series of Catholic pilgrimages has begun across the United States this weekend, with2024-05-21Chinese companies shine at MWC
Chinese technology companies are in the limelight at the ongoing Mobile World Congress 2024, a major2024-05-21Apple reportedly cancels EV project, to focus more on AI
After spending billions of dollars and a decade on research, Apple reportedly is dropping building a2024-05-21China's demand to hit the peak for petroleum products before 2025
China's demand for petroleum products may reach its peak before 2025, amid the country's green energ2024-05-21Analysis: Larson enters conversation with Verstappen as best drivers in the world
INDIANAPOLIS (AP) — Ask almost any hardcore motorsports fan who the best driver in the world is righ2024-05-21- A deputy to the National People's Congress (NPC) called for efforts to tackle shortage and bottlenec2024-05-21
atest comment